Clinical Trial Update: Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous peripheral blood stem cell transplant followed by donor bone marrow transplant in high-risk B- and T-cell lymphomas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Prolymphocytic Leukemia
• Childhood Hodgkin Lymphoma
• Childhood Non-hodgkin Lymphoma
• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Hypodiploidy
• Loss of Chromosome 17p
• Non-hodgkin Lymphoma
• Plasma Cell Leukemia
• Plasma Cell Myeloma
• Progression of Multiple Myeloma or Plasma Cell Leukemia
• Small Lymphocytic Lymphoma
• T
• T-cell Prolymphocytic Leukemia
• Waldenström Macroglobulinemia

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: B-Cell Prolymphocytic Leukemia, Hypodiploidy | Phase 2 | Status: COMPLETED | Results posted: 2019-05-29